With a focus on NYC dealmakers and Israel startups, this event will present the latest trends in international life sciences investing and industry collaboration. NYC BIO, the Government of Israel Economic Mission to North America (and MATIMOP) will host hand-picked Israeli start-ups developing breakthrough therapies and will address their international commercialization challenges. A panel discussion with keynote speakers will follow. Goodwin Procter partner Steve Davis will participate.
Stephen M. DavisPartner